Insider · CIK 0001741937
Matt Davidson
Files at ADIL (ADIAL PHARMACEUTICALS, INC.). First filing -, latest -.
In brief
Matt Davidson files SEC Form 4 as officer and director at ADIL (ADIAL PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Matt Davidson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | AGrant or award Common Stock | +61,647 | - | - | 61,647 | Jun 16, 2026 |
| Jun 11, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | AGrant or award Common Stockindirect: By Matt and Alli Davidson Trust | +3,427 | - | - | 3,427 | Jun 16, 2026 |
| Jun 12, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | AGrant or award Common Stock | +232,417 | $0.00 | $0 | 297,491 | Jun 16, 2026 |
| Jun 11, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | AGrant or award Series A Preferred Stock | +1,822 | - | - | 1,822 | Jun 16, 2026 |
| Jun 11, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | AGrant or award Series A Preferred Stockindirect: By Matt and Alli Davidson Trust | +101 | - | - | 1,923 | Jun 16, 2026 |
| Jun 12, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +232,417 | $0.00 | $0 | 232,417 | Jun 16, 2026 |
Questions about Matt Davidson
Answered from the filings on this page, as of the latest one.
Is Matt Davidson buying or selling?
Matt Davidson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Matt Davidson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Matt Davidson has 0.
Where does Matt Davidson file Form 4?
Matt Davidson has filed Form 4 at ADIL (ADIAL PHARMACEUTICALS, INC.) as Chief Development Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.